SCHEMBL7290248

SCHEMBL7290248

CN(C)CCCN(C(=O)Cc1ccccc1)c1ccccc1SCc1ccccc1

nearest known ligand 0.69

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
NPY2R P49146 7/20 0.69
TRPM8 Q7Z2W7 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
KMT2A Q03164 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
PTPRC P08575 1/20 0.39
MAPT P10636 4/20 0.38
MAPK1 P28482 2/20 0.38
GAA P10253 1/20 0.38
POLB P06746 1/20 0.37
MITF O75030 1/20 0.37
LMNA P02545 1/20 0.37
IDE P14735 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Oxalic Acid SCHEMBL7291345 0.95 NPY2R (0.63) NPY2RTRPM8SMN1; SMN2KDM4EALDH1A1
SCHEMBL7288694 0.93 NPY2R (0.61) NPY2RTRPM8SMN1; SMN2KDM4EALDH1A1
SCHEMBL7290591 0.93 NPY2R (0.61) NPY2RTRPM8SMN1; SMN2KDM4EALDH1A1
SCHEMBL7288507 0.93 NPY2R (0.58) NPY2RTRPM8SMN1; SMN2KDM4EALDH1A1
SCHEMBL7298617 0.92 NPY2R (0.59) NPY2RSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL9736030 0.92 NPY2R (0.59) NPY2RSMN1; SMN2KDM4EALDH1A1KMT2A
SCHEMBL7297873 0.89 NPY2R (0.67) NPY2RSMN1; SMN2KMT2AMAPTMAPK1
SCHEMBL7290237 0.88 NPY2R (0.69) NPY2RKMT2AL3MBTL1PTPRC
SCHEMBL7290404 0.87 NPY2R (0.65) NPY2RALDH1A1KMT2AL3MBTL1MAPT
SCHEMBL7293830 0.85 NPY2R (0.51) NPY2RTRPM8SMN1; SMN2KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP claimed
US-5116851-A Administering antiischemic and antiarrhythmia agents E. R. SQUIBB & SONS, INC. (US) 1992-05-26 US disclosed
EP-0453658-A2 Use of substituted anilides and sulfonamides in the treatment of cardiovascular diseases E.R. SQUIBB & SONS, INC. (US) 1991-10-30 EP disclosed